Year: 2019

Mead Johnson Nutrition And Ewopharma Launch Nutramigen Puramino In The Czech Republic And Slovakia

Nijmegen, 23 January, 2017: Mead Johnson Nutrition announces that it has signed an agreement with Ewopharma, a leading distributor of harmaceutical and nutritional products in Central Eastern Europe, to launch Nutramigen PURAMINO in the Czech Republic and Slovakia. Nutramigen PURAMINO is a hypoallergenic amino-acid formula indicated as a complete alimentary solution for infants and young … Read more

Ewopharma Strengthens Its Oncology Business

Schaffhausen, 22nd June 2017: Ewopharma, a pharmaceutical marketing company and Eisai Co., Ltd. (TYO: 4523), a leading global research and development-based pharmaceutical company are pleased to announce that as of 1st April 2017 Ewopharma acquired the rights to commercialise several of Eisai’s products in eleven countries in Central and Eastern Europe (CEE). Ewopharma will commercialise … Read more

Shield Therapeutics And Ewopharma Sign Feraccru Licence Agreement For Switzerland

London, UK, 6th July 2017: Shield Therapeutics plc (LSE:STX), a speciality pharmaceutical company focused on secondary care, and Ewopharma AG, a pharmaceutical marketing company headquartered in Schaffhausen, Switzerland, are pleased to announce that they have entered into an exclusive sale, supply, distribution and marketing agreement for Feraccru® in Switzerland.a Under the terms of the agreement, … Read more